NESS ZIONA, Israel, October 3, 2017 /PRNewswire/ --
NRGene, the worldwide
NRGene has integrated part of Monsanto's genomic data into GenoMAGICTM, a cloud-based big data analytics platform, thereby allowing Monsanto to evaluate the ability of the integrated platform to predict, compare and select the best genetic makeup for molecular breeding.
"We have been impressed with NRGene's integrated analytics platform so far and look forward to evaluating its impact on our molecular breeding program," said Dr. Tom Osborn, Molecular Breeding Technology Director for Monsanto.
GenoMAGICTM was developed by a unique mix of highly experienced algorithm designers, software engineers, plant breeders, and plant geneticists and is used by seed companies like Monsanto and major academic and research institutions around the world to support the fight against world hunger. Genomes from NRGene include key global food crops like wheat, maize, sorghum, and sweet potatoes.
"Comprehensive genome analysis is the next major step to accelerate development of the new generation of crops," said Dr. Gil Ronen, Chief Executive Officer of NRGene. "If successful, the GenoMAGICTM platform will improve Monsanto's genomics and trait data evaluation to enable more efficient development of new varieties."
Monsanto's R&D pipeline encompasses a broad range of solutions to help farmers mitigate the complex challenges they face on the farm - whether caused by pests, disease or weather - while improving their productivity and environmental sustainability. GenoMAGICTM delivers greater breadth and depth to Monsanto's ability to discover traits, enhance genomes, and for genomic selection.
NRGene is a genomic big data company developing cutting-edge software and algorithms to reveal the complexity and diversity of crop plants, animals, and aquatic organisms for supporting the most advanced and sophisticated breeding programs. NRGene tools have already been employed by some of the leading seed companies worldwide as well as the most influential research teams in academia. www.nrgene.com
Amy Kenigsberg K2 Global Communications firstname.lastname@example.org +1-913-440-4072 (+7 ET) +972-9-794-1681 (+2 GMT)
Subscribe to our Free Newsletters!
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...
Therapeutic drug monitoring is measuring drug concentrations at specific intervals in a patient's ...
Sweet's syndrome or acute febrile neutrophilic dermatosis is a skin disorder with no specific ...View All